论文信息 - Hepatic adverse event profile of inotuzumab ozogamicin in adult patients with relapsed or refractory acute lymphoblastic leukaemia: results from the open-label, randomised, phase 3 INO-VATE study. - 字舞流文

Hepatic adverse event profile of inotuzumab ozogamicin in adult patients with relapsed or refractory acute lymphoblastic leukaemia: results from the open-label, randomised, phase 3 INO-VATE study.

H. Kantarjian | E. Jabbour | D. DeAngelo | S. O'brien | A. Merchant | A. Advani | T. Uchida | Hui Zhang | N. Fujishima | E. Vandendries | R. Cassaday | D. Marks | M. Stelljes | P. Kebriaei | A. Ejduk | M. Calbacho | B. Sleight | Akil A. Merchant